Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / LLY - AbCellera Biologics: Bebtelovimab Supply Deal Provides A Much Needed Shot In The Arm

LLY - AbCellera Biologics: Bebtelovimab Supply Deal Provides A Much Needed Shot In The Arm

Eli Lilly and Company
  • AbCellera announced on Thursday Feb 10th a supply deal with the US government and Lilly for Bebtelovimab, the AbCellera developed pan COVID variant antibody treatment.
  • The supply deal includes an initial 600,000 doses valued at $720 million with an option for an additional 500,000 doses.
  • AbCellera shares have fallen off of a cliff as of late and this news, along with hopefully formal EUA approval for Bebtelovimab should place a solid floor under shares.

For further details see:

AbCellera Biologics: Bebtelovimab Supply Deal Provides A Much Needed Shot In The Arm
Stock Information
Company Name: Eli Lilly and Company
Stock Symbol: LLY
Market: NYSE
Website: lilly.com
Menu
LLY LLY Quote LLY Short LLY News LLY Articles LLY Message Board
Get LLY Alerts

News, Short Squeeze, Breakout and More Instantly...